NCT01776918

Brief Summary

Metabolic diseases and mitochondrial disorders are caused by genetic mutation which lead to disruptions in energy producing pathways in our body. Enough energy or calories must be given in the diet to ensure normal growth and development. Currently, energy needs for patients with metabolic and mitochondrial diseases are not measured, but is estimated using a mathematical equation based on healthy children. This may lead to under feeding or overfeeding of calories, and has negative nutritional implications. The clinical standard for measuring energy needs is the use of indirect calorimeter.The indirect calorimeter takes individualized measurements for each patient and therefore will enable dietitians and clinicians to provide sufficient calories in the diet to better manage the disease and promote normal growth and development. We believe daily energy requirements will vary within metabolic diseases (Phenylketonuria) and mitochondrial disorders (mitochondrial fatty acid oxidation defect, POLG1 mutation etc.). The objective of this preliminary study is to measure resting energy expenditure in children living with metabolic and mitochondrial conditions and data obtained will be used to generate future hypothesis and will form a basis for future studies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2012

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2012

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

January 17, 2013

Completed
11 days until next milestone

First Posted

Study publicly available on registry

January 28, 2013

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
Last Updated

July 18, 2017

Status Verified

July 1, 2017

Enrollment Period

2.3 years

First QC Date

January 17, 2013

Last Update Submit

July 13, 2017

Conditions

Keywords

POLG1 MutationPhenylketonuria

Outcome Measures

Primary Outcomes (1)

  • Resting Energy Expenditure

    Resting Energy Expenditure will be measured by carbon dioxide production and oxygen consumption.

    1 hour

Study Arms (2)

Metabolic Disease- Phenylketonuria

Mitochondrial disorder

Eligibility Criteria

Age1 Year - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children (1-18y) diagnosed with either phenylketonuria or a mitochondrial disorder

You may qualify if:

  • Children(1-18y) who are diagnosed with either Phenylketonuria (PKU) or a mitochondrial disorder

You may not qualify if:

  • Children, less than 1y old, who are diagnosed with PKU or a mitochondrial disorder, as it is difficult to perform indirect calorimeter on them.
  • Children(1-18y) who are not diagnosed with PKU or a mitochondrial disorder
  • Children(1-18y) who are diagnosed with either PKU or a mitochondrial disorder, but are currently experiencing illness such as fever, cold, vomiting or diarrhea

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Child & Family Research Institute

Vancouver, British Columbia, V5Z4H4, Canada

Location

MeSH Terms

Conditions

Mitochondrial DiseasesPhenylketonurias

Condition Hierarchy (Ancestors)

Metabolic DiseasesNutritional and Metabolic DiseasesBrain Diseases, Metabolic, InbornBrain Diseases, MetabolicBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesAmino Acid Metabolism, Inborn ErrorsMetabolism, Inborn ErrorsGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Rajavel Elango, PhD

    Child & Family Research Institute/University of British Columbia

    PRINCIPAL INVESTIGATOR
  • Sylvia Stockler-Ipsiroglu

    University of British Columbia/Faculty of Pediatrics

    STUDY CHAIR
  • Ramona Meni Salvarinova Zivkovic

    University of Bristish Columbia/Faculty of Pediatrics

    STUDY CHAIR
  • Howard Parsons

    University of British Columbia/Faculty of Pediatrics

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle Investigator

Study Record Dates

First Submitted

January 17, 2013

First Posted

January 28, 2013

Study Start

February 1, 2012

Primary Completion

June 1, 2014

Study Completion

September 1, 2014

Last Updated

July 18, 2017

Record last verified: 2017-07

Locations